News
RVTY
157.36
+3.85%
5.83
Revvity initiated with an Outperform at William Blair
TipRanks · 4h ago
How Child Diabetes Screening Launch At Revvity (RVTY) Has Changed Its Investment Story
Simply Wall St · 4h ago
Weekly Report: what happened at RVTY last week (0928-1002)?
Weekly Report · 15h ago
Moderna, Illumina lead healthcare gains in September as medtech drags
Seeking Alpha · 2d ago
Press Release: Revvity to Hold Earnings Call on November 3, 2026
Dow Jones · 3d ago
Revvity to Hold Earnings Call on November 3, 2026
Barchart · 3d ago
Invesco S&P 500 Equal Weight ETF Experiences Big Outflow
NASDAQ · 5d ago
Revvity (RVTY) Launches T1D Screening Kit, Is The Upside Already Priced In?
Simply Wall St · 09/28 19:14
Weekly Report: what happened at RVTY last week (0921-0925)?
Weekly Report · 09/28 09:42
1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds
Barchart · 09/28 04:04
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Revvity (RVTY)
TipRanks · 09/26 13:00
Did Diabetes Screening Kit Launch Just Shift Revvity (RVTY) Stock Investment Narrative?
Simply Wall St · 09/25 23:19
Full Transcript: Revvity Q2 2026 Earnings Call
Benzinga · 09/25 09:22
Biotech Stocks At 52-Week Highs - CDNA +13%, GRAL +15%, TWST +16%, ADPT, RVTY
NASDAQ · 09/25 08:39
Here’s How Much You Would Have Made Owning Revvity Stock In The Last 15 Years
Benzinga · 09/24 21:45
Revvity Inc. Stock Climbs 6.0%, Outperforms Peers
Dow Jones · 09/24 20:34
Revvity Inc. stock outperforms competitors on strong trading day
MarketWatch · 09/24 20:30
Stocks Finish Mostly Lower as Bond Yields Soar
Barchart · 09/24 15:37
Early notable gainers among liquid option names on September 24th
TipRanks · 09/24 13:55
Revvity launches GSP T1D 3plex kit
TipRanks · 09/24 12:26
More
Webull provides a variety of real-time RVTY stock news. You can receive the latest news about Revvity Inc through multiple platforms. This information may help you make smarter investment decisions.
About RVTY
Revvity, Inc. provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. It has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards life sciences customers. The segment offers instruments, reagents, software, subscriptions, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the areas of reproductive health and emerging market diagnostics. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.